08:33 AM EDT, 07/31/2026 (MT Newswires) -- IRadimed ( IRMD ) reported Q2 non-GAAP earnings Friday of $0.46 per diluted share, compared with $0.49 a year earlier.

Two analysts polled by FactSet expected $0.44.

Revenue for the quarter ended June 30 was $20.5 million, compared with $20.4 million a year earlier.

Two analysts surveyed by FactSet expected $20.4 million.

The company said it expects Q3 adjusted earnings per share of $0.54 to $0.59, along with revenue of $23 million to $24.5 million.

Two analysts expect $0.54 and $23.7 million, respectively.

For the full year, IRadimed ( IRMD ) continues to expect adjusted earnings per share of $2.09 to $2.24 and revenue of $91 million to $96 million.

Two analysts expect $2.08 and $91.2 million, respectively.